Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: The North Dublin population stroke study

Stroke

Volumn 42, Issue 4, 2011, Pages 1021-1029

  Chróinín, Danielle Ní ^a   Callaly, Elizabeth L ^b   Duggan, Joseph ^a   Merwick, Áine ^a   Hannon, Niamh ^a   Sheehan, Q́rla ^a   Marnane, Michael ^a   Horgan, Gillian ^a   Williams, Emma B ^a   Harris, Dawn ^a   Kyne, Lorraine ^a   McCormack, Patricia M E ^b   Moroney, Joan ^c   Grant, Tim ^d   Williams, David ^c,e   Daly, Leslie ^d   Kelly, Peter J ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b Stroke and Hypertension Unit   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

acute prescription; acute stroke; neuroprotectants; outcomes; statins

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FATALITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHYSICAL DISABILITY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; STROKE PATIENT; SURVIVAL; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CHOLESTEROL; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IRELAND; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE; SURVIVAL RATE; TIME;

EID: 79954581852     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.596734     Document Type: Article

References (30)

1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278.
2. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2008;355:549-559.
3. Cimino M, Balduini W, Carloni S, Gelosa P, Guerrini U, Tremoli E, Sironi L. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology. 2005; 26:929-933. (Pubitemid 41427533)
4. Cakmak A, Yemiçsçi M, Köksoy C, Yazgan U, Dinçer D, Dalkara T. Statin pre-treatment protects brain against focal cerebral ischemia in diabetic mice. J Surg Res. 2007;138:254-258. (Pubitemid 46365720)
5. Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001;32:980-986.
6. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1998;95:8880-8885. (Pubitemid 28350583)
7. Kawashima S, Yamashita T, Miwa Y, Ozaki M, Namiki M, Hirase T, Inoue N, Hirata K, Yokoyama M. HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke. 2003;34:157-163. (Pubitemid 36070817)
8. Sironi L, Cimino M, Guerrini U, Calvio AM, Lodetti B, Asdente M, Balduini W, Paoletti R, Tremoli E. Treatment with statins after induction of focal ischaemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol. 2003;23:322-327. (Pubitemid 36231947)
9. Berger C, Xia F, Maurer MH, Schwab S. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev. 2008;58:48-56. (Pubitemid 351852927)
10. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53: 743-751. (Pubitemid 36622511)
11. Di Napoli P, Taccardi AA, Oliver M, De Caterina R. Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J. 2002;23: 1908-1921. (Pubitemid 35448549)
12. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology. 2005;65:253-258. (Pubitemid 41022370)
13. Aslanyan S, Weir CJ, McInnes GT, Reid JL, Walters MR, Lees KR. Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol. 2005;12:493-498. (Pubitemid 40956804)
14. Yoon SS, Dambosia J, Chalela J, Ezzeddine M, Warach S, Haymore J, Davis L, Baird AE. Rising statin use and effect on ischemic stroke outcome. BMC Med. 2004;2:4.
15. Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke. 2004;35:1117-1121.
16. Reeves MJ, Warner Gargano J, Luo Z, Mullard AJ, Jacobs BS, Majid A; for the Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. Effect of pre-treatment with statins on ischemic stroke outcomes. Stroke. 2008;39:177985.
17. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005;36:1298-1300. (Pubitemid 40798758)
18. Stead LG, Vaidyanathan L, Kumar G, Bellolio MF, Brown RD Jr, Suravaram S, Enduri S, Gilmore RM, Decker WW. Statins in ischemic stroke: just low-density lipoprotein lowering or more? J Stroke Cerebrovasc Dis. 2009; 18:124-127.
19. Bushnell CD, Griffin J, Newby LK, Goldstein LB, Mahaffey KW, Graffagnino CA, Harrington RA, White HD, Simes RJ, Califf RM, Topol EJ, Easton JD. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke. 2006;37:1427-1431. (Pubitemid 44305721)
20. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961-969. (Pubitemid 47562312)
21. Montaner J, Chacón P, Krupinski J, Rubio F, Millán M, Escudero D, Hereu P, Molina CA, Quintana M, Alvarez-Sabín J. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol. 2008;15:82-90. (Pubitemid 350265291)
22. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, MacLeod MJ, Sillesen H, Zweifler R, Michael K, Welch A, Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009;40:3526-3531.
23. Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J. Statin treatment withdrawal in ischemic stroke: a controlled randomised study. Neurology. 2007;69:904-910. (Pubitemid 47329591)
24. Central Statistics Office Ireland 2007. Census of Population of Ireland 2006. Volumes 1, 2. Dublin, Ireland: Stationary Office; 2006.
25. Feigin VL, Carter K. Editorial comment-Stroke incidence studies one step closer to the elusive gold standard? Stroke. 2004;35:2045-2047. (Pubitemid 39129557)
26. World Health Organization. Cerebrovascular disorders. Geneva: World Health Organization; 1978.
27. Elkind MS, Sacco RL, Macarthur RB, Peerschke E, Neils G, Andrews H, Stillman J, Corporan T, Leifer D, Liu R, Cheung K. High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). Cerebrovasc Dis. 2009;28:266-275.
28. Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, Ibrahim T. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Intern Med. 2009;169: 1658-1667.
29. Ribó M, Jimenez C, Muñoz F, Canovas D, Krupinski J, Martinez-Zabaleta M, de la Torre Laviana FJ, Freijo M, Arenillas JF, Segura T, Flores M. STARS07. Stroke treatment with acute reperfusion and simvastatin. http:// www.strokecenter.org/trials/trialDetail.aspx?tid-1067&search
30. Elkind MS. NeuSTART II. Neuroprotection with Statin Therapy for Acute Recovery Trial (Neu START): A phase 2 safety and pilot efficacy study of lovastatin for the treatment of acute ischemic stroke. http://www.strokecenter. org/trials/trialDetail.aspx?tid-971&search